Mukul Agrawal Takes Fresh Position in Pharma Stock - Equitymaster

JAGSNPHARM   636.65  9.80  1.52%   
Under 61% of Jagsonpal Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Jagsonpal Pharmaceuticals Limited stock suggests that many investors are alarmed at this time. Jagsonpal Pharmaceuticals' investing sentiment shows overall attitude of investors towards Jagsonpal Pharmaceuticals Limited.
  
Mukul Agrawal Takes Fresh Position in Pharma Stock Equitymaster

Read at news.google.com
Google News at Macroaxis
  

Jagsonpal Pharmaceuticals Fundamental Analysis

We analyze Jagsonpal Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jagsonpal Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jagsonpal Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Jagsonpal Pharmaceuticals is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Jagsonpal Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jagsonpal Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Jagsonpal Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Jagsonpal Pharmaceuticals by comparing valuation metrics with similar companies.

Complementary Tools for Jagsonpal Stock analysis

When running Jagsonpal Pharmaceuticals' price analysis, check to measure Jagsonpal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jagsonpal Pharmaceuticals is operating at the current time. Most of Jagsonpal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jagsonpal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jagsonpal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jagsonpal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data